Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

While the COVID-19 pandemic is behind us, conspiracy theories, much like the virus itself, haven’t gone anywhere. And the latest bizarre claim about the vaccine is, let’s just say, a bit out of the ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centred on text messages she exchanged with the head of vaccine maker Pfizer during negotiations for Covid jabs, her lawyer ...

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

The internet is full of false claims. Columnist Sam Kirton shares why fact-checking is important, particularly for the rare disease world.

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...